S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
New York lawmakers pass $237 billion budget with policies to jump-start housing market
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
New York lawmakers pass $237 billion budget with policies to jump-start housing market
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
New York lawmakers pass $237 billion budget with policies to jump-start housing market
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
New York lawmakers pass $237 billion budget with policies to jump-start housing market
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis

Axsome Therapeutics (AXSM) Earnings Date, Estimates & Call Transcripts

$67.90
+2.18 (+3.32%)
(As of 04/19/2024 ET)

Earnings Summary

Upcoming
Earnings Date
May. 6
Before Market Opens
Confirmed
Actual EPS
(Feb. 20)
-$0.73 Beat By $0.48
Consensus EPS
(Feb. 20)
-$1.21
Skip Charts & View Estimated and Actual Earnings Data

AXSM Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

AXSM Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Axsome Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20244($1.33)($1.26)($1.30) 
Q2 20244($1.26)($1.08)($1.19) 
Q3 20244($1.05)($0.93)($0.99) 
Q4 20244($0.91)($0.78)($0.84) 
FY 202416($4.55)($4.05)($4.32) 
Q1 20253($1.00)($0.82)($0.93) 
Q2 20253($0.63)($0.03)($0.40) 
Q3 20253($0.29)$0.51$0.06 
Q4 20253$0.13$1.39$0.66 
FY 202512($1.79)$1.05 ($0.61)

AXSM Earnings Date and Information

Axsome Therapeutics last announced its earnings results on February 20th, 2024. The reported ($0.73) EPS for the quarter, topping analysts' consensus estimates of ($1.21) by $0.48. The business earned $71.53 million during the quarter, compared to the consensus estimate of $70.38 million. Axsome Therapeutics has generated ($5.20) earnings per share over the last year (($5.20) diluted earnings per share). Earnings for Axsome Therapeutics are expected to grow in the coming year, from ($3.81) to $0.53 per share. Axsome Therapeutics has confirmed that its next quarterly earnings report will be published on Monday, May 6th, 2024. Axsome Therapeutics will be holding an earnings conference call on Monday, May 6th at 8:00 AM Eastern. Interested parties can register for or listen to the call..

Axsome Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/6/2024
Confirmed)
-------  
2/20/2024Q4 2023($1.21)($0.73)+$0.48$0.62$70.38 million$71.53 million
11/6/2023Q3 2023($1.24)($1.32)($0.08)($1.32)$54.88 million$57.79 million    
8/7/2023Q2 2023($1.24)($1.00)+$0.24($0.46)$40.19 million$46.70 million
5/8/2023Q1 2023($1.13)($0.22)+$0.91($0.18)$26.87 million$94.58 million
2/27/2023Q4 2022($1.18)($1.28)($0.10)($1.15)$21.51 million$24.37 million    
11/7/2022Q3 2022($1.10)($1.03)+$0.07($0.99)$16.59 million$16.85 million
8/9/2022Q2 2022($1.19)($1.06)+$0.13($1.06)$9.59 million$8.82 million    
5/2/2022Q1 2022($1.02)($1.03)($0.01)($1.03)--    
3/1/2022Q4 2021($0.99)($0.90)+$0.09($0.90)--    
11/8/2021Q3 2021($0.95)($0.93)+$0.02($0.93)--    
8/8/2021Q2 2021($0.88)($0.86)+$0.02($0.86)--    
5/9/2021Q1 2021($0.83)($0.78)+$0.05($0.78)--  

Axsome Therapeutics Earnings - Frequently Asked Questions

When is Axsome Therapeutics's earnings date?

Axsome Therapeutics has confirmed that its next quarterly earnings data will be published on Monday, May 6th, 2024. Learn more on AXSM's earnings history.

Did Axsome Therapeutics beat their earnings estimates last quarter?

In the previous quarter, Axsome Therapeutics (NASDAQ:AXSM) reported ($0.73) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.21) by $0.48. Learn more on analysts' earnings estimate vs. AXSM's actual earnings.

How much revenue does Axsome Therapeutics generate each year?

Axsome Therapeutics (NASDAQ:AXSM) has a recorded annual revenue of $270.60 million.

How much profit does Axsome Therapeutics generate each year?

Axsome Therapeutics (NASDAQ:AXSM) has a recorded net income of -$239.24 million. AXSM has generated -$5.20 earnings per share over the last four quarters.

What is Axsome Therapeutics's EPS forecast for next year?

Axsome Therapeutics's earnings are expected to grow from ($3.81) per share to $0.53 per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:AXSM) was last updated on 4/21/2024 by MarketBeat.com Staff

From Our Partners